SPL
Massive earnings potential for Vivagel.
At least 100m USD/annum , very conservatively, more likely double that.
Only drug in a billion USD market.
This gives 7 bucks per share based upon Vivagel alone.
The DEP platform is the main game;
DEP docetaxel trial almost finished. Chemo drug without hair loss or neutropenia.
Multi billion dollar market.
Astrazenica has licensed a couple of candidates. 100s of millions in milestone payments and 15 percent royalties for each drug.
Many other strings to their bow.
Sounds retarded, but could see a 50 dollar SP in the future.
Should be a good day trade. Over 6m outstanding shorts. Make em piss...
Cheers
- Forums
- ASX - Day Trading
- DT Pre Market Jan 13 2017
SPL Massive earnings potential for Vivagel. At least 100m...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus